Oculus Innovative Sciences Prepares to Initiate Clinical Study for Use of Microcyn(R) Hydrogel in Management of Scars Based Upon FDA-Reviewed Protocol May 11, 2012
Oculus Innovative Sciences Microcyn(R) Technology to be Showcased at the Columbia University 10th Annual Innovations in Complex Vascular & Endovascular Interventions in New York City on May 10-11, 2012 May 9, 2012
Oculus Innovative Sciences' Microcyn Acute Care Products Showcased at Symposium on Advanced Wound Care in Atlanta Apr 26, 2012
Photo Release -- Napa Valley Nutritionals, a Newly Formed Division of Oculus Innovative Sciences, Introduces Glucorein(TM) Medical Food for Management of Glucose Levels in Pre-Diabetics and Type 2 Diabetics Apr 19, 2012
Oculus Innovative Sciences Provides Business Update From Roth Capital 23rd Annual Growth Conference Mar 23, 2012
Oculus Innovative Sciences Partner, Eloquest Healthcare, Launches Microcyn(R) Wound Care Products Into U.S. Hospitals, Ambulatory Surgical and Acute Care Centers Mar 6, 2012
Oculus Innovative Sciences Partner, Quinnova Pharmaceuticals, Launches Microcyn(R)-Based Atrapro(TM) Products Feb 21, 2012
Oculus Innovative Sciences Announces Fiscal Third Quarter 2012 Financial Results and Conference Call Jan 19, 2012